
Golip 105mg Tablet
Marketer
Golgi Usa Research Laboratories LLP
Salt Composition
Fenofibrate (105mg)
Overview Golip 105mg Tablet
Cholesto-Stat 105mg tablets effectively manage elevated cholesterol. This medication lowers harmful LDL ("bad") cholesterol and triglycerides, concurrently increasing beneficial HDL ("good") cholesterol. Reduced cholesterol levels significantly decrease the risk of stroke and heart attack. Always adhere to your physician's prescribed dosage and regimen for Cholesto-Stat 105mg tablets. Consumption can be anytime, with food, but maintaining daily consistency is recommended. High cholesterol often presents no symptoms, yet discontinuing treatment can worsen your condition, potentially elevating cholesterol and increasing cardiovascular risks. Regular cholesterol monitoring is essential. This medication forms part of a comprehensive treatment plan that includes a balanced diet, regular physical activity, smoking cessation, moderate alcohol consumption, and weight management. While you can maintain a normal diet, minimizing high-fat foods is advisable. Commonly reported side effects include nausea, vomiting, diarrhea, and stomach discomfort. Inform your doctor about all current medications before starting Cholesto-Stat 105mg tablets. Caution is advised for individuals with liver or kidney conditions. Pregnant or breastfeeding women should seek medical counsel prior to use.
Primary Ingredients of Golip 105mg Tablet
No text was provided to rewrite.
Uses of Golip 105mg Tablet
Elevated cholesterol and triglyceride levels
Major Benefits of Golip 105mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Golip 105mg Tablets should be administered with a meal.
Common Side effects of Golip 105mg Tablet:
- Abdominal pain
- Diarrhea
- Nausea
- Headache
- Flatulence
- Vomiting
- Increased liver enzymes
- Increased creatine phosphokinase (CPK) level in blood
- Back pain
- Inflammation of the nose
How to use Golip 105mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Golip 105mg tablets should be administered with a meal.
How Golip 105mg Tablet works:
Lipitor 105mg tablets reduce lipid levels. This medication decreases triglycerides and low-density lipoprotein ("bad") cholesterol, concurrently increasing high-density lipoprotein ("good") cholesterol.
SAFETY ADVICE
AlcoholUNSAFE
Combining Golip 105mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Golip 105mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Golip 105mg tablets are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Golip 105mg Tablets.
KidneyCAUTION
Patients with kidney impairment should use Golip 105mg Tablets cautiously, potentially requiring dosage modification under medical supervision. Golip 105mg Tablets are contraindicated in individuals with severe kidney disease.
LiverUNSAFE
The use of Golip 105mg Tablets is contraindicated in patients with hepatic impairment; avoid use in such cases. Seek medical advice before administering. Patients with severe liver disease should not take Golip 105mg Tablets.
What if you forget to take Golip 105mg Tablet :
Should you forget to take your Golip 105mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Golip 105mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Fibric acid-based compound |
| Developing Habits | No. |
| Treatment Category | HEART |
| Action Class | Fibrates (PPARα agonists) |
